Your browser doesn't support javascript.
loading
Principles and functions of condensate modifying drugs.
Patel, Avinash; Mitrea, Diana; Namasivayam, Vigneshwaran; Murcko, Mark A; Wagner, Michael; Klein, Isaac A.
Afiliação
  • Patel A; Dewpoint Therapeutics GmbH, Dresden, Germany.
  • Mitrea D; Dewpoint Therapeutics, Boston, MA, United States.
  • Namasivayam V; Dewpoint Therapeutics GmbH, Frankfurt, Germany.
  • Murcko MA; Dewpoint Therapeutics, Boston, MA, United States.
  • Wagner M; Dewpoint Therapeutics GmbH, Frankfurt, Germany.
  • Klein IA; Dewpoint Therapeutics, Boston, MA, United States.
Front Mol Biosci ; 9: 1007744, 2022.
Article em En | MEDLINE | ID: mdl-36483537
Biomolecular condensates are compartmentalized communities of biomolecules, which unlike traditional organelles, are not enclosed by membranes. Condensates play roles in diverse cellular processes, are dysfunctional in many disease states, and are often enriched in classically "undruggable" targets. In this review, we provide an overview for how drugs can modulate condensate structure and function by phenotypically classifying them as dissolvers (dissolve condensates), inducers (induce condensates), localizers (alter localization of the specific condensate community members) or morphers (alter the physiochemical properties). We discuss the growing list of bioactive molecules that function as condensate modifiers (c-mods), including small molecules, oligonucleotides, and peptides. We propose that understanding mechanisms of condensate perturbation of known c-mods will accelerate the discovery of a new class of therapies for difficult-to-treat diseases.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article